Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B

Maricel G Miguelino, Jerry S Powell Division of Hematology and Oncology, University of California Davis Medical Center, Sacramento, CA, USA Abstract: Hemophilia B is an X-linked genetic disease caused by mutation of the gene for coagulation protein factor IX (FIX), with an incidence of approximat...

Full description

Bibliographic Details
Main Authors: Miguelino MG, Powell JS
Format: Article
Language:English
Published: Dove Medical Press 2014-08-01
Series:Patient Preference and Adherence
Online Access:http://www.dovepress.com/clinical-utility-and-patient-perspectives-on-the-use-of-extended-half--peer-reviewed-article-PPA